Thirty-fourth Report
The guidelines define criteria for the evaluation of the safety,
efficacy, and quality of herbal medicines, and thereby assist national
regulatory authorities, scientific organizations, and manufacturers in
undertaking an assessment of the documentation/submissions/dossiers on
such products. These guidelines were developed at the request of the
Fourth and Fifth International Conference of Drug Regulatory Authorities
(ICDRA) meetings.
http://apps.who.int/medicinedocs/en/d/Jh2984e/
No comments:
Post a Comment